Science & Research

New research by Israeli firms Eybna and CannaSoul Analytics suggests that a combination of CBD and terpenes might be effective against the deadly cytokine storms that are symptomatic of COVID-19.

The FDA has opened public comments for new preliminary guidance from the agency for cannabis pharmaceutical research.

New research from the University of California, Irvine has determined that cannabis is a safe and potentially effective treatment for the chronic pain associated with sickle cell disease.

A recent investigation from the Routledge Handbook of Interdisciplinary Cannabis Research exposes the harsh reality of indoor cannabis cultivation’s negative environmental impact.

Lawmakers in the House of Representatives have advanced a highways infrastructure bill that includes language making products from state-legal cannabis markets available for federal research purposes.

Canadian researchers suggest that certain cannabinoid extractions could help to quell an immune system response to the coronavirus that has proven fatal in some patients; the study was published as a pre-print, meaning it has not been peer-reviewed.

FSD Pharma has received FDA permission to design and submit an application for a new trial using a synthetic cannabinoid-based drug in the treatment of COVID-19.

A recent industry analysis found that Leafs By Snoop is the most recognizable cannabis brand, followed by Cheeba Chews and Marley Natural.

A recent study published in the journal Pain found that CBD treatment for dogs with osteoarthritis was beneficial in 9 out of 10 cases.

Researchers have identified a material found on altars at the entrance of an ancient Judahite shrine as cannabis; experts say the cannabis was likely used for its mind-altering effects.

A recent study suggests that female cannabis users experience more intense cannabis cravings than their male counterparts.

A recent study published in Frontiers in Psychology suggests there is no evidence suggesting that just prenatal cannabis exposure can lead to significant cognitive impairments.

A recently published Preprints study found that the cannabinoids THC and CBD could help to down-regulate the production of proteins that are key in spreading the coronavirus among humans.

Canadian researchers behind a 10-year survey have suggested that setting the legal age for cannabis access at 19 would help avoid some potential adverse health effects.

A localized survey of 500 Hash Bash attendees in Michigan showed that even among the most enthusiastic consumers, knowledge about cannabinoid content and cannabis dosing can be very limited.

Australian researchers have uncovered evidence that a cannabis-based treatment could be effective against chronic insomnia.

Researchers have confirmed the effectiveness of a cannabis “tolerance break,” demonstrating that cannabis tolerance is linked to neurometabolic alterations in the brain’s reward circuitry.

There are many conflicting reports about the safety of cannabis use for pregnant women. Here’s what we know:

New York City-based Mind Medicine announced it had partnered with the world-leading psychedelics pharmacology and clinical research laboratory at University Hospital Basel in Switzerland.

Canadian cannabis healthcare technology company Cannalogue has applied to conduct clinical trials investigating potential cannabis-based treatments for COVID-19.

Researchers at the University of Southern Denmark have uncovered evidence that CBD can help antibiotics in the fight against antibiotic-resistant bacteria.

The DEA has unveiled a new rule proposal that would finally open up the licensing of new research-grade cannabis cultivators.

The UCLA Cannabis Research Initiative has been awarded a $3.9 million grant to investigate whether cannabis terpenes can help reduce the use of opioids in pain treatment.

A study published last month shows that cannabis could be an effective and safer alternative treatment for fibromyalgia symptoms.